Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reduction of Capital

17 Dec 2018 16:43

RNS Number : 7400K
Seneca Growth Capital VCT PLC
17 December 2018
 

ANNOUNCEMENT FOLLOWING REDUCTION OF CAPITAL

 

Seneca Growth Capital VCT Plc

 

Reduction of Capital

 

The Board of Seneca Growth Capital VCT Plc (the "Company") announces that the proposed Share Premium Reduction and Capital Redemption Reserve Reduction have now taken place.

 

On 15 December 2017 Seneca Growth Capital VCT Plc issued a circular to its shareholders to convene a general meeting on 19 January 2018, at which (amongst other things) shareholders were asked to approve a reduction of capital by the cancellation of the share premium account of the Company as at the date an order is made confirming the cancellation by the High Court (the "Share Premium Reduction"). The amount credited to the share premium account, and now cancelled, arose as a result of the issue of B ordinary shares on 23 August 2018 and 27 September 2018 at a premium.

 

At its annual general meeting on 5 April 2018, the shareholders of the Company were asked to approve a restructuring of the issued share capital of the Company pursuant to which ordinary shares of £0.50 each were sub-divided and re-designated into ordinary shares of £0.01 and deferred shares of £0.49 each (the "Deferred Shares"). At the same meeting, shareholders gave the Company authority to buy back and cancel all of the Deferred Shares in addition to approving a reduction of capital by the cancellation of the capital redemption reserve of the Company, as at the date an order is made confirming the cancellation by the High Court (the "Capital Redemption Reserve Reduction" and together with the Share Premium Reduction being referred to as the "Capital Reductions").

 

On 7 December 2018, the High Court of Justice in Manchester confirmed the Capital Reduction. The court order approving the Capital Reductions was registered by the Registrar of Companies on 11 December 2018 and, therefore, the Capital Reductions became effective on that date.

 

The reserve created by the Capital Redemption Reserve Reduction can be used at any time at the Board's discretion once the accounts for 2018 have been lodged at Companies House; however use of the reserve created from Share Premium Reduction cannot be used for returning any funds to shareholders for a period of three years following the end of the accounting period in which the allotment of B ordinary shares to which the share premium related, due to restrictions imposed by VCT regulations.

 

There is no change to the number of ordinary shares or B ordinary shares in issue as a result of the Capital Reductions, and for the avoidance of doubt, the rights attaching to those shares following the Capital Reductions remain unchanged.

 

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKAXFDNPFFF
Date   Source Headline
25th Mar 20227:01 amGNWNAV Update
25th Mar 20227:00 amGNWFinal Results for the Year Ended 31 December 2021
8th Mar 20227:00 amGNWInterim Dividend on B Shares
10th Dec 202111:40 amGNWDirector/PDMR Shareholding
8th Dec 20213:24 pmGNWIssue of Equity and Total Voting Rights
16th Nov 20217:00 amGNWSecond Interim Dividend on B Shares
29th Oct 202111:42 amGNWOffer for Subscription and Publication of Prospectus
28th Oct 20211:06 pmGNWTR-1: Notification of major holdings
21st Oct 20219:01 amGNWNAV Update
16th Sep 202112:16 pmRNSSecond Price Monitoring Extn
16th Sep 202112:14 pmRNSPrice Monitoring Extension
14th Sep 20212:07 pmRNSSecond Price Monitoring Extn
14th Sep 20212:01 pmRNSPrice Monitoring Extension
25th Aug 20214:41 pmRNSSecond Price Monitoring Extn
25th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20214:42 pmRNSSecond Price Monitoring Extn
12th Aug 20214:38 pmRNSPrice Monitoring Extension
26th Jul 20217:00 amGNWHalf-year report
15th Jun 202112:18 pmGNWIssue of Equity and Total Voting Rights
15th Jun 20217:00 amGNWB Share Net Asset Value
3rd Jun 202110:51 amGNWInterim Capital Dividend on Ordinary Shares
20th May 20217:00 amGNWB Share Extension of Offer
28th Apr 202110:52 amGNWIssue of Equity and Total Voting Rights
1st Apr 20215:29 pmGNWDirector/PDMR Shareholding
1st Apr 202111:36 amGNWIssue of Equity and TVR
31st Mar 20217:00 amGNWNet Asset Value(s)
29th Mar 20215:12 pmGNWResult of AGM
4th Mar 20215:26 pmGNWDirector/PDMR Shareholding
2nd Mar 202112:50 pmGNWIssue of Equity and Total Voting Rights
24th Feb 20211:49 pmGNWIssue of Prospectus
23rd Feb 20217:00 amGNWFinal Results and NAV Update
18th Feb 20217:00 amGNWDividend Declaration
10th Dec 20203:57 pmGNWDirector/PDMR Shareholding
9th Dec 20203:49 pmGNWIssue of Equity and Total Voting Rights
5th Nov 20207:00 amGNWDividend Declaration
13th Oct 20204:22 pmGNWOffer for Subscription
5th Oct 20207:00 amGNWSecond Interim Capital Dividend
5th Oct 20207:00 amGNWNAV Update
16th Sep 20207:00 amGNWInvestment Realisations and NAV
21st Aug 202010:55 amGNWChange of Registered Office
30th Jul 20207:00 amGNWHalf-year report
10th Jul 202011:43 amGNWIssue of Equity
24th Jun 202012:35 pmGNWB Share - Extension of Offer
13th May 20203:03 pmGNWPublication of a supplementary prospectus
29th Apr 202012:45 pmGNWIssue of Equity
29th Apr 20207:00 amGNWResult of Annual General Meeting
27th Apr 20206:52 pmGNWUpdate on Omega, Optibiotix and NAVs
20th Apr 20206:36 pmGNWOmega Diagnostics, Net Asset Value, New B Share Pool Investments
7th Apr 20204:35 pmGNWIssue of Supplementary Prospectus
3rd Apr 20202:10 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.